INDUCTION of general anaesthesia tends to impair pulmonary gas exchange and to cause a reduction in the partial pressure of oxygen in arterial blood. A number of factors account for this, such as reduction of functional residual volume, abnormal ventilation perfusion ratio (VA/0), closure of airways and micro-atelectasis; ~ but of these the most important determinant of net gas exchange in the lungs is the relative matching of ventilation and blood flow. z While the distribution of both ventilation and blood flow is governed mainly by gradients of transpleural pressure and hydrostatic vascular pressures, there is some local modification of the distribution of blood flow in hypoxic regions by pulmonary vasoconstriction. Thus, local flow tends to decrease, causing the VA/Q ratio to increase and, as Hauge 3 found in awake subjects, the resulting increased pulmonary vascular resistance (PVR) triggered by alveolar hypoxia causes blood to be redistributed away from poorly ventilated to better ventilated regions. The net result of this response is to minimize arterial oxygen desaturation. When anaesthetized dogs are subjected to alveolar hypoxia, the rise in PRV is inversely and linearly related to arterial oxygen saturation, but the slope of this response varies greatly between animals. 4 Evidence is accumulating that many inhalational anaesthetics in clinically useful concentrations may attenuate or abolish this response, so potentiating the development and persistence of low VA]I~ ratios in regions of the lungs of the anaesthetized subject. 5 Studies on isolated perfused lungs have shown that halothane and methoxyfluorane reduce this protective response of the pulmonary vascula- Canad. Anaesth. Soc. J., vol. 26, no. 1, January 1979 ture to hypoxia. 6' 7 More recent studies on isolated lung lobes demonstrated even greater inhibition of hypoxic pulmonary vasoconstriction by fluoroxene, and isofluorane. 8 In intact animals, however, the effect of these halogenated anaesthetics on pulmonary vascular resistance (PVR) during hypoxic breathing is unclear. As indicated above, our previous studies in the dog 4 demonstrated great variation between individuals in the PVR response to hypoxia expressed in terms of arterial oxygen saturation, but in any one individual the response was highly significant and reproduceable. Further, a low PVR response resulted in a much greater arterial oxygen desaturation at equivalent levels of inspired oxygen than occurred in animals with high PVR responses. Attenuation of the hypoxic PVR response by inhalational anaesthetics could potentiate arterial oxygen desaturation. It would be useful in these circumstances to be able to predict those individuals at risk from severe arterial oxygen desaturation.
We have therefore measured the PVR responses to hypoxia in intact dogs with and without exposure to halothane and correlated these with arterial oxygen saturation.
MATERIALS AND METHODS
The experimental design which was used is shown in Figure 1 .
Ten adult mongrel dogs (weight range 17-34kg) were anaesthetized with intravenous pentobarbitone (30 mg-kg), paralyzed with pancuronium (0.06mg'kg) intubated with a cuffed tracheal tube and placed in the supine position. Supplemental doses of anaesthetic and muscle relaxant were administered as required to ensure an adequate level of anaesthesia and muscle paralysis during each hypoxic episode.
Ventilation was controlled with intermittent positive pressure ventilation (IPPV) from a Harvard respirator. Tidal volume and frequency were set using the Radford nomogram and held constant throughout the experiment. Catheters were placed in each femoral artery for pressure recording and arterial blood gas sampling and in 6 the left femoral vein for administration of drugs and sampling of blood for determination of haemoglobin and haematocrit. A triple lumen thermistor tipped Swan-Ganz catheter was placed through the right femoral vein into the pulmonary artery for measurement of pulmonary artery pressure (Ppa), pulmonary wedge pressure (PWP) and cardiac output (0) by the thermodilution method using an Edwards cardiac output computer (9510-A). Pulmonary arterial blood was sampled for mixed venous blood gas estimation.
Continuous monitoring of respired concentrations of oxygen and carbon dioxide was made by rapid gas analyzers (Beckman OM-1102 analyser, LB-2 gas analyzer). Mixed expired carbon dioxide samples were obtained using a mixing box in the expiratory line and were measured at the end of each control and hypoxic period.
Other parameters measured were airway pressure, electrocardiogram and rectal temperature by thermistor probe. All pressures were measured by Statham (P37b) transducers which, together with breath to breath oxygen and carbon dioxide concentrations and electrocardiogram were recorded on Beckman Dynograph (R411) and Hewlett Packard (HP2201) pen recorders. Blood gases were measured in an Instrumentation Laboratory "pH/gas analyzer" using the microelectrode method. Calibration by tonometry was done throughout each experiment. Calculation of arterial oxygen saturation (Sao2) was done using the Rossing and Cain equation for dog blood 9 as previously described. 4
Pulmonary vascular resistance (PVR) was calculated from:
During an initial 60-minute set-up period, oxygen was added to the inspired air to give an Sao2 of more than 98 per cent, and thereafter the same oxygen-air mixture was used during recovery periods, and during halothane exposure.
At the end of this set-up period, baseline values of all parameters were obtained by serial estimation. Hypoxia was then induced by switching to an inspired mixture of oxygen in nitrogen for five minutes, using inspired oxygen concentrations of 8, 11, 15, or 20 per cent, followed by a 30-minute recovery period after each exposure. Hypoxic PVR responses were thus established for each animal, before exposure to halothane.
The animal was then ventilated for 15 minutes with halothane 1.5 per cent and submitted to five minutes of alveolar hypoxia followed by a further 30-minute recovery period breathing the oxygen-air mixture. This sequence was then repeated four times using different levels of hypoxia under halothane anaesthesia.
Control and halothane normoxic values for all parameters refer to those recorded at the end of each recovery period and after 15 minutes of exposure to halothane 1.5 per cent respectively, while hypoxic values refer to those recorded after five minutes of exposure to hypoxia with or without exposure to halothane. In our previous study 4 on the effects of hypoxia alone, we have shown that all parameters measured reach a plateau in less than four minutes after switching to inspiration of hypoxic oxygen/nitrogen mixture.
Statistical Methods: Data were analysed by Student paired t-tests. Linear regression analysis was done by analysis of variance of paired values. Statistical significance was taken as P = 0.05 or less.
RESULTS

Sequential changes in PVR during normoxic breathing
The effect of repeated exposure to halothane and different levels of hypoxia was examined by comparing successive PVR values at normoxia. Figure 2 shows each of the four consecutive control PVR and three halothane values for each animal with the group means (+ 1 SD) indicated.
Control PVR (open circles) increased progressively so that after the fourth experimental se- FIGURE 2 Pulmonary vascular resistance at normoxia after consecutive exposure to O.,-air controls (open circles) and to halothane (closed circles). The mean value for all dogs _+1 SD is indicated. Measurements after calcium infusion are shown on the right. Mean values are not statistically different at the 5 per cent probability level.
quence it was about 18 per cent above the initial value. A similar increase was found for PVR measured after 15 minutes ofhalothane exposure (closed circles) at normoxia. At the beginning of each halothane induction, PVR increased by about 6 per cent over the preceding control value, but did not change appreciably thereafter during normoxic breathing. None of these changes are statistically significant, but similar trends occurred in each case.
At the end of each experiment, calcium chloride (10 mg' kg) was injected intravenously and the PVR response to hypoxia was measured. Increasing extracellular calcium did not alter baseline PVR nor the response to hypoxia.
The sequential changes in mean 0 are shown in Figure 3 for each of four control periods and three halothane exposures at normoxia with mean values (+__ 1 SD) indicated. Control cardiac output decreased by 24 per cent throughout the experiment, but this was not statistically significant.
At the end of the first period ofhalothane exposure at normoxia, 0 was about 31 per cent less than the preceding control (column 2), but was only 19 per cent less at the end of the third exposure. Only an 8 per cent change occurred in 0 between the first and the last exposure, to halothane.
A similar trend was found for pulmonary artery pressure (Ppa) but the magnitude of the change was much less than for Q. Halothane decreased mean Ppa by 6 per cent on the first and second exposures. After the third halothane exposure mean Ppa increased very slightly by one per cent. While the changes in mean values of PVR, Ppa and (~ were not statistically significant, the trends quoted above occurred in all dogs. Heart rate, electrocardiogram and airway pressure remained unaltered duringnormoxic breathing. Hypoxia caused a small increase in heart rate (~ 6b/rain) at an inspired oxygen of 20 per cent but heart rate was reduced progressively with decreasing inspired oxygen, so that the mean reduction was 11 b/rain when inspired oxygen was 8 per cent. No arrhythmias were noted. Mean airway pressure increased slightly in all dogs with hypoxia by a mean of one per cent above controls, but this was not statistically significant. Halothane reduced heart rate (~ 8 b/min) and airway pressure (2 per cent of controls) while halothane plus hypoxia resulted in a further reduction in heart rate (~ 14 b/min compared to controls), but increased airway pressure to equal control values. No arrhythmias were induced by hypoxia during halothane exposure.
Responses of puhnonary vascular resistance to hypoxia
A regression analysis of the PVR response to different levels of hypoxia with and without halothane exposure was done in all animals and is summarized in Table I . The linear slopes of these PVR responses to hypoxia are shown in Figure 4 for each of the 10 dogs, plotted as PVR against Sao2. For the sake of clarity, these have been drawn as two groups of five dogs each.
The solid lines labelled with the small letters show the PVR slopes for each animal with hypoxia alone (control hypoxic PVR response) Table I. while the hatched lines labelled with the corresponding capital letters are the PVR slopes after exposure to halothane. As in our previous study, 4 the control PVR responses were statistically significant (P < 0.01) inverse relationships with Saoe but showed great variability between dogs. The range of slopes was from -0.003 to -0.203 with a mean of -0.058 and a mean correlation coefficient of 0.938. Those dogs represented on the left panel of Figure 4 (a to e) and including dog "i'" on the right panel were low responders whereas dogs "f", "'g", "h", and "'j'" were high responders (right panel in Figure 4 ).
The slopes of the PVR responses after halothane exposure were also statistically highly significant (P < 0.01) and showed inverse linear relationships with Sao2, with slopes in the range from -0.012 to -0.237. The mean slope was -0.096 with a mean correlation coefficient of 0.858. Halothane increased the absolute values of PVR at all levels of Sao2 in all 10 dogs but the change in the PVR slope after exposure to halothane was variable. Low responders showed a range in slopes after halothane from -0.048 to -0.071 with a mean of -0.059 and mean correlation coefficient of 0.837. High responders on the other hand, had slopes after halothane which ranged from -0.112 to -0.237 with a mean of -0.162 and a mean correlation coefficient of 0.890. It is evident from Figure 4 that the low responders (those showing little or no increase in control PVR with hypoxia) increased PVR least after halothane. These dogs also had the most severe arterial desaturation during control hypoxic and halothane exposures. On the other hand, the high responders showed least arterial oxygen desaturation during control hypoxic and halothane exposures. In all cases as a result of increased PVR during halothane exposure, the Sao2 was slightly greater at equivalent levels of PVR than with hypoxia alone.
Pulmonary artery pressure increased with hypoxia under halothane anaesthesia but the absolute values of Ppa were lower than with hypoxia alone. Statistically significant inverse linear relationships were found for Ppa against Saozsimilar to those described above for PVR, with the exception of one dog "i", where the linear correlation with hypoxia was not significant. This contrasts with a significant correlation between PVR and Sao2 in this dog (Table I) . PVR responses were significant at P = 0.01 or less following halothane exposure in all dogs. The regression analysis of these data are summarized in Table II . The range of slopes for Ppa with Sao2 with hypoxia alone was -0.025 to -0.694 and after halothane was -0.051 to -0.488. The overall mean slopes for Ppa in control responses and after halothane were -0.199 and -0.238, giving mean correlation coefficients of 0.910 and 0.887 respectively.
An analysis of variance (ANOVA) was done of control hypoxic PVR and Ppa slopes versus the slopes after halothane exposure to determine whether these were altered in a consistent and predictable manner. The ANOVA showed a highly significant relationship between the control hypoxic slopes for both PVR and for Ppa against the slopes after halothane. These data were also subjected to linear regression analysis and highly significant correlations were found so that the halothane PVR slope (baH) was given by: bRH = 0.899ba -0.048• where ba is the control PVR slope, significant at P = 0.001, and with a correlation coefficient r = 0.933.
The above relationship, together with the paired control and halothane slope values, are shown in Figure 5 . Clearly if the control PVR response is known, the PVR response following halothane can be predicted with a high degree of accuracy. Similar predictions can be obtained for Ppa from the halothane Ppa slope (bpH) where bpH = 0.462bp -0.149, (bo is the control slope, r = 0.870 and P = 0.003). 
Mean changes with halothane
The uniqueness of the Ppa and PVR responses resulted in great variation between animals, so that group means showed little change and are mentioned here to allow comparison of the effects of halothane with halothane plus hypoxia. The mean cardiac output increased by 17 per cent with hypoxia, whereas induction with halothane caused an overall reduction in cardiac output of about 26 per cent and only a one per cent increase was obtained with hyp0xia plus halothane. This contrasts with the mean PVR which increased by 21 per cent with hypoxia alone; and while only a small increase was found with halothane at normoxia, a highly significant increase of 42 per cent was found with halothane plus hypoxia. Mean Ppa increased to about the same extent (29 per cent) with both hypoxia alone and halothane plus hypoxia. A small reduction in Ppa (6 per cent occurred at normoxia with halothane, and persisted with halothane plus hypoxia. Halothane increased pulmonary wedge pressure (PWP) slightly in all dogs (mean increase 3 mm Hg). Thus, since Ppa was reduced, the net perfusion pressure was decreased. On the other hand, the decrease in cardiac output was much greater and resulted in a net increase in PVR at normoxia. Hypoxia did not further increase PWP or cardiac output during halothane exposure but since Ppa was increased, PVR was also increased. In summary then, halothane did not diminish the pressor response to any great extent but did abolish the cardiac response to hypoxia. Figure 7 shows mean values for VD/VT ratio, arterial carbon dioxide tension and mixed expired carbon dioxide as a fractional concentration in the control (open circles) and halothane (closed circles) groups at normoxia (C) and hypoxia (H).
VD/VT ratio increased with halothane at normoxia by about 9 per cent and decreased by 3 per cent during hypoxia plus halothane. In the control group VD/VT ratio was reduced by about 8 per cent with hypoxia. Since VT was constant in these experiments, these changes reflect changes in VD alone.
End-tidal carbon dioxide concentration as well as arterial and mixed venous carbon dioxide ten- sions decreased slightly with halothane at normoxia and were further decreased with hypoxia, but there was no significant difference in arterial carbon dioxide tension between the control and halothane groups.
The alveolar to arterial oxygen tension difference decreased with halothane exposure at normoxia, but this was not significant (P = 0.1); but a significant decrease occurred with halothane plus hypoxia, from 42.6 to 1.1 mm Hg. Little variation was found for alveolar to arterial oxygen tension difference between dogs.
Puhnona~ shunt fraction Figure 8 shows 0s/(~t plotted against Sao2 for each dog. Values of Qs/0t decreased exponentially in both control (open circles) and halothane (closed circles) groups. It can be seen from Figure  8 that halothane caused a small decrease in shunt fraction at equivalent levels of Saoz. In five instances during halothane exposure this resulted in negative values for 0s/(~t. due to the fact that mixed venous blood had a higher oxygen content than in alveoli at the end of five minutes of hypoxic breathing in these dogs. This could be interpreted as evidence that changes in shunt flow had not reached equilibrium after five minutes of halothane plus hypoxia exposure. However, our previous study 4 has shown that negative (~s/0t and P(A -a)o2 values are possible during equilibrium at low levels of hypoxic breathing in some animals, although in the present study these were only found after exposure to halothane.
DISCUSSION
The variability of the pulmonary vascular response to alveolar hypoxia, whether expressed in terms of pulmonary vascular resistance (PVR) or pulmonary arterial pressure (Ppa), confirms our previous findings. 4 As before, the inverse relationships of PVR and Ppa with arterial oxygen saturation were highly significant and reproduceable. Exposure to halothane and other inhalational anaesthetic agents has been shown in studies on isolated perfused lungs to reversibly depress this pressor response to hypoxia 6'~°-~3 while in human subjects the response to unilaterial hypoxia is also depressed. 8 The constriction of pulmonary arterial vessels serving a region where alveolar hypoxia is present has been shown to divert pulmonary blood flow away from such regions to regions which are better oxygenated (higher alveolar oxygen tension), thereby minimizing arterial oxygen desaturation? 4-t6 If indeed inhalational anaesthetics depress this protective response, one might expect relatively more blood would flow to poorly ventilated or hypoxic regions in the lung and resulting arterial hypoxaemia.
There seems little doubt that in conditions of constant pulmonary blood flow in isolated lung studies in animals 6 and in conditions of regional hypoxia in man, 8 that halothane anaesthesia aggravates arterial oxygen desaturation through the mechanisms postulated above. However, in the intact animal subjected to whole lung hypoxia we found that the reduction in the pressor response is exceeded by the reduction in cardiac output, resulting in an increase in the PVR response at equivalent levels of arterial oxygen saturation. In these circumstances, then, the shift in PVR compared to arterial oxygen saturation increased rather than decreased the effectiveness of this protective mechanism. This is also indicated by our results for alveolar to arterial oxygen tension difference and pulmonary shunt fraction, which were slightly reduced on exposure to halothane at normoxia, but significantly reduced with hypoxia in the presence of halothane. These findings are surprising since it is generally accepted that the alveolar to arterial oxygen tension difference and pulmonary shunt fi-action are increased during general anaesthesia. TM Various mechanisms have been suggested to explain the resulting hypoxaemia; altered lung recoil, airway closure, alveolar atelectasis, reduced functional residual capacity, and alveolar hypoxia. 19'2° It seems unlikely that airway closure or alveolar atelectasis occurred in our preparation since all animals were artificially ventilated with IPPV and no progressive changes of arterial oxygen tension or saturation, or of airway pressures were found during control periods. However, dead space, which here included apparatus dead space, increased with exposure to halothane and accounted for the increase in VD/VT ratio which we found, thus confirming early work in man 21 and dogs z2 Tbe alveolar component of physiological dead space will be increased during anaesthesia by any factor which reduces pulmonary blood flow or pressure. Inhalation of halothane resulted in a reduction of both cardiac output and pulmonary arterial pressure and it seems reasonable to assume that these account for the change in dead space. The reduction which we found for mixed expired carbon dioxide with halothane contrasts with the absence of any significant change in arterial carbon dioxide, indicating a possible disequilibrium state in terms of alveolar ventilation or alternatively altered carbon dioxide production.
The maintenance of arterial oxygen saturation in these circumstances could occur if there was only a small reduction in arterial oxygen tension or a shift in the oxygen/haemoglobin dissociation curve to the left, or both. We did find a small increase in arterial pH but little change in arterial oxygen tension on four exposures to halothane.
An increase in PVR with whole lung alveolar hypoxia would redistribute pulmonary blood flow to areas of higher alveolar oxygen only if the magnitude of the pressor response varied with the regional alveolar oxygen tension. Maloney and co-workers -'3 have shown that such a mechanism exists in sheep, so that areas normally receiving the bulk of pulmonary blood flow show the greatest rise in Ppa and PVR with hypoxia. Further, these areas are those which normally have the lowest alveolar oxygen tension. Our results suggest a similar mechanism exists in the dog.
The lack of any change in the increase in Ppa with hypoxia on exposure to halothane contrasts with studies in isolated lungs 6'7 and humans. 5 We did find a reduction in the absolute values of Ppa at all levels of hypoxia plus halothane compared to hypoxia alone, but the pressor response was not abolished or significantly attenuated by halothane. The anaesthetic concentrations used were similar and were calculated to achieve a MAC value of one. It is possible that these reflect species differences; however, a more likely reason in our view is that the significant ,eduction in cardiac output we found resulted in augmentation of the hypoxic responses. It has recently been shown in dogs that increased pulmonary blood flow during dextran infusion results in blunting of the hypoxic pressor response z4 and the converse would seem equally true, namely that ,-educed pulmonary blood flow would result in increase of the hypoxic pressor response.
Such a mechanism would require that the blunted hypoxic pressor response seen in isolated lungs during halothane exposure 6,7 at constant blood flow could be recovered by lowering cardiac output. Further studies are required to clarify the exact role of halothane in these circumstances. It is of interest that the infusion of calcium after multiple halothane and hypoxic exposures did not alter the baseline PVR or its response to hypoxia, indicating that excitationcoupling was not diminished. This lends further weight to the hypothesis proposed that the haemodynamic factors may be an important determinant of the in vivo pulmonary vascular response to alveolar hypoxia.
SUMMARY
The pulmonary vascular response to alveolar hypoxia with and without halothane exposure was measured in dogs. Hypoxia increased pulmonary artery pressure IPpa) and pulmonary vascular resistance (PVR) so that in each case inverse linear relationships were found with arterial oxygen saturation. These responses were highly significant and reproduceable but varied greatly between individuals. Halothane administration resulted in an increased slope of PVR against oxygen saturation due to the fact that reduction in cardiac output exceeded the reduction in Ppa. An analysis of variance showed that it was possible to predict accurately the hypoxic 13 PVR and Ppa responses under halothane anaesthesia from the control hypoxic responses. Animals with low PVR responses showed the greatest arterial oxygen desaturation with hypoxia, whereas high responders showed least oxygen desaturation. Thus it was possible to predict tbose individuals at risk from severe arterial oxygen desaturation under halothane anaesthesia.
R~SUMI~
La r6ponse vasculaire pulmonaire h l'hypoxie alv6olaire seule et pendant l'exposition I'halothane a 6t6 mesur6e chez des chiens. L'hypoxie a augment6 la pression art6rielle pulmonaire et la r6sistance vasculaire pulmonaire selon une relation lin6aire inverse h la saturation du sang art~riel en oxyg~ne. Les r6ponses 6talent trbs significatives et reproductibles mais variaient beaucoup d'un individu hun autre. L'administration d'halothane augmentait la pente de la r~sistance vasculaire pulmonaire en fonction de la saturation en oxyg6ne, ceci '~ cause d'une reduction plus grande du d6bit cardiaque que de la pression de I'art~re pulmonaire. Une analyse de variation a montr6 qu'il 6tait possible de pr6dire pr6cis6ment les changements de la r6sis-tance vasculaire pulmonaire et de la pression arterielle pulmonaire sous anesthesie h l'halothane h partir des r6ponses h l'hypoxie seule. Les animaux chez lesquels la r6sistance pulmonaire repondait peu h Fhypoxie pr6sen-taient le plus haut degr6 de desaturation en oxyg~ne, alors que ceux qui r~pondaient le plus h l'hypoxie montraient des d6saturations moindres en oxyg~ne. I1 devenait possible de conna~tre les individus pr6sentant un risque de d6saturation art6rielle s6v~re sous anesth6sie ~ I'halothane.
